Definitive Contract 75F40124C00121
Award Date 9/9/24
Potential Completion Date 5/9/26
Potential Value $1.1M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Mountain View, CA 94040, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Food and Drug Administration awarded a $607,840 delivery order to Dnanexus, Inc. for its PrecisionFDA Collaborative Omics Environment in the cloud. Dnanexus will provide its cloud-based platform as a service under a firm fixed price contract to support FDA's regulatory science programs. The place of performance will be in Silver Spring, Maryland. The one year contract starts in August 2021 and runs through August 2022 to give FDA researchers access...
- The Department of Health and Human Services Food and Drug Administration awarded a $2.8 million firm fixed price delivery order contract to Dnanexus, Inc. for its PrecisionFDA Collaborative Omics Environment in the cloud. Dnanexus will deliver its cloud-based precisionFDA platform to support the FDA's regulatory science programs over a one year period of performance ending in September 2022. No subcontractors or set aside designations were identified. This contract leverages Dnanexus' existing...
- This federal contract award was granted by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit corporate entity based in Mountain View, California. The $6,755,725.98 Firm Fixed Price Delivery Order contract is for Dnanexus to provide the PrecisionFDA platform, a FISMA-authorized secure cloud-based data repository and analysis platform for FDA researchers, reviewers, bioinformaticians, and data scientists to enable collaboration on regulatory science and precision medicine...
- The Department of Health and Human Services Food and Drug Administration awarded a $2.232 million delivery order contract to Dnanexus, Inc. to provide a PrecisionFDA Collaborative Omics Environment in the cloud. With a completion date of September 29, 2020 and no set-aside designation, this time and materials contract supports the FDA's efforts to advance regulatory science through an open data sharing platform for multi-omics data analysis. Located in Mountain View, California, Dnanexus will...
- This is a firm fixed price delivery order contract awarded by the Food and Drug Administration (FDA) to Dnanexus, Inc., a for-profit organization providing cloud-based genomics data management and analysis services. The $796,885.33 contract supports the FDA's PrecisionFDA program, which aims to advance regulatory science through precision medicine approaches. Dnanexus will provide cloud platform services, bioinformatics software, and database services to support the PrecisionFDA collaborative...
- Dnanexus, Inc. was awarded a firm fixed price delivery order valued at one hundred ninety-four thousand five hundred ninety-eight dollars and thirteen cents ($194,598.13) by the Department of Health and Human Services' Food and Drug Administration (FDA). This delivery order, with a period of performance through September 2023 and no set-aside designation, is issued against Dnanexus' twenty million dollar ($20M) indefinite delivery contract for ongoing provision of the FDA's PrecisionFDA...
- Dnanexus, Inc. was awarded a $3,419,094.15 firm fixed price delivery order by the Department of Health and Human Services' Food and Drug Administration to provide continued development services for the agency's PrecisionFDA Increment D program. Under this delivery order issued against the company's existing $20 million small business set-aside indefinite delivery contract with the FDA for ongoing PrecisionFDA Collaborative Omics Environment support, Dnanexus will deliver operations, development,...
- The National Institutes of Health (NIH) awarded DNAnexus, Inc. a $15 million Other Transaction Agreement on May 20, 2025, for the Advanced Analysis for Precision Cancer Therapy (ADAPT) Treatment and Analysis Platform (TAP) initiative. The contract extends through May 19, 2031, and will be performed at DNAnexus's headquarters in Mountain View, California. Under this award, DNAnexus will develop and maintain a cloud-based platform designed to support precision cancer therapy research through...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a firm-fixed-price purchase order contract to Dnanexus, Inc. for a "Biobank Research Analysis Platform." The $12,569.50 contract does not have a set-aside designation and is for the delivery of cloud-based genomics data management and analysis services from Dnanexus, a for-profit organization. Through this award, Dnanexus will provide bioinformatics software,...
- This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services, National Institutes of Health, National Cancer Institute to Dnanexus, Inc. for the procurement of the DnaNexus bioinformatic cloud computing platform license and support. The total potential value of the contract is $120,000.00, and the period of performance will end on September 18, 2024. The contract does not have a set-aside designation. Dnanexus, Inc. will provide cloud-based genomics...